#United States #San Francisco #Accuray #Astro #Adaptive Radiotherapy

Accuray's Upcoming Analyst Event at ASTRO 2025

On September 29, 2025, Accuray Incorporated, a leading innovator in radiation therapy, will host a significant analyst discussion during the American Society of Radiation Oncology (ASTRO) Annual Meeting, held in San Francisco, California. This event aims to bridge the gap between analysts, investors, and the latest innovations in the field of radiation medicine. It presents an excellent opportunity for industry experts to exchange insights and perspectives.

The event will kick off at 1:30 PM PT (4:30 PM ET), and attendees will have the option to participate either in person at the ASTRO meeting or via a virtual platform. This hybrid format ensures that both local and international guests can engage with the discussions.

Key Topics of Discussion

Participants can expect profound insights from global thought leaders in the field of adaptive radiotherapy. The agenda includes pivotal topics such as:

• - The Adaptive Radiotherapy Spectrum: Programmatic Vision

Discussions will explore the overarching goals and visions of adaptive radiotherapy, emphasizing its potential to enhance patient outcomes.

• - Integration of Adaptive Radiotherapy into Practice: Workflow Realities

Experts will share practical insights about how adaptive radiotherapy can be seamlessly integrated into existing workflows in clinical settings.

• - Motion Management and Imaging Leadership: The Global Perspective

This segment will focus on advancements in motion management and the implications of imaging technologies on adaptive radiotherapy.

These topics are critical as adaptive radiotherapy evolves, presenting medical professionals with the tools to customize treatments based on real-time patient needs.

Registration Information

In order to attend the Accuray event, both in-person and virtual guests must complete registration by September 25, 2025. Interested participants can RSVP through the provided link to secure their spot. Accuray emphasizes the necessity of early registration to ensure a smooth experience for all attendees.

About Accuray Incorporated

Accuray is committed to transforming radiation therapy to improve patient lives significantly. The company has been at the forefront of innovation, developing market-changing solutions that address various patient requirements, from complex cases to more routine treatments. With a dedication to continuous improvement and a focus on clinical partnerships, Accuray aims to empower healthcare practitioners to enhance their patient care strategies and expedite recovery.

Headquartered in Madison, Wisconsin, Accuray operates globally, collaborating with healthcare teams to continuously elevate standards in oncology and neuro-radiosurgery.

For inquiries regarding investor relations or media contacts, Accuray encourages interested parties to reach out:

• - Aman Patel, CFA, Investor Relations, ICR Healthcare: +1 (443) 450-4191, [email protected]
• - Beth Kaplan, Public Relations Director: [email protected]

The future of radiation therapy is bright with companies like Accuray leading the charge, and this forthcoming event promises to offer valuable insights that can significantly impact patient care in the years to come.